BE711997A - - Google Patents

Info

Publication number
BE711997A
BE711997A BE711997DA BE711997A BE 711997 A BE711997 A BE 711997A BE 711997D A BE711997D A BE 711997DA BE 711997 A BE711997 A BE 711997A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE711997A publication Critical patent/BE711997A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
BE711997D 1967-03-10 1968-03-11 BE711997A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEF0051784 1967-03-10
DEF0054258 1967-12-08

Publications (1)

Publication Number Publication Date
BE711997A true BE711997A (ko) 1968-09-11

Family

ID=25977598

Family Applications (1)

Application Number Title Priority Date Filing Date
BE711997D BE711997A (ko) 1967-03-10 1968-03-11

Country Status (11)

Country Link
US (1) US3551493A (ko)
AT (7) AT304470B (ko)
BE (1) BE711997A (ko)
CH (2) CH525184A (ko)
DE (1) DE1668055B2 (ko)
DK (1) DK133095C (ko)
FR (2) FR1575615A (ko)
GB (1) GB1215751A (ko)
NL (1) NL154204B (ko)
NO (1) NO125723B (ko)
SE (1) SE338987B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758303A (fr) * 1969-11-03 1971-04-30 Roussel Uclaf Nouveaux derives du 1-amino 3-phenoxy 2-propanol et procede de preparation
US4018824A (en) * 1969-11-28 1977-04-19 Teikoku Hormone Mfg. Co., Ltd. 1-Aryloxy-3-aminopropane derivatives
US4360464A (en) * 1969-11-28 1982-11-23 Teikoku Hormone Mfg. Co. Ltd. Process for production of 1-aryloxy-aminopropane derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
FR2361106A2 (fr) * 1976-08-10 1978-03-10 Mar Pha Etu Et Expl De Marques Nouvelles terpeno-phenoxy-alkylamines
DE3012012A1 (de) * 1980-03-28 1981-10-08 Beiersdorf Ag, 2000 Hamburg Substituierte 3-aryl-2-cycloalken-1-one und verfahren zu ihrer herstellung
CN1023402C (zh) * 1988-06-03 1994-01-05 伊莱利利公司 制备5-羟色胺拮抗药的方法
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
DK0759299T3 (da) * 1995-08-16 2000-08-07 Lilly Co Eli Potensering af serotoninrespons
US7034059B2 (en) * 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
EP2959904A1 (en) 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Methods for treating, diagnosing and prognosing a haematological malignancy
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Also Published As

Publication number Publication date
AT304470B (de) 1973-01-10
DE1668055C3 (ko) 1974-05-02
AT304473B (de) 1973-01-10
DE1618386B2 (de) 1975-09-18
FR1575615A (ko) 1969-07-25
DE1618386A1 (de) 1971-03-25
DK133095C (da) 1976-08-23
NL154204B (nl) 1977-08-15
FR8070M (ko) 1970-07-15
US3551493A (en) 1970-12-29
NL6803035A (ko) 1968-09-11
AT291973B (de) 1971-08-10
AT291972B (de) 1971-08-10
AT304469B (de) 1973-01-10
AT291971B (de) 1971-08-10
GB1215751A (en) 1970-12-16
SE338987B (ko) 1971-09-27
DE1668055A1 (de) 1971-07-15
CH525184A (de) 1972-07-15
NO125723B (ko) 1972-10-23
DE1668055B2 (de) 1973-09-06
DK133095B (da) 1976-03-22
CH508584A (de) 1971-06-15
AT289066B (de) 1971-04-13

Similar Documents

Publication Publication Date Title
AU425114B2 (ko)
AU416737B2 (ko)
AU2277767A (ko)
AU342066A (ko)
AU2528767A (ko)
AU1273466A (ko)
AU610966A (ko)
AU2116667A (ko)
AU2256867A (ko)
AU3189468A (ko)
AU2977667A (ko)
AU97666A (ko)
BE609869A (ko)
AU3054676A (ko)
AU2406369A (ko)
AU23366A (ko)
AU34866A (ko)
AU408412B2 (ko)
AU1868267A (ko)
AU1763766A (ko)
AU459699A (ko)
AU1677166A (ko)
AU1614766A (ko)
BE710328A (ko)
BE162295A (ko)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: FARBWERKE HOECHST A.G. VORMALS MEISTER LUCIUS & B

Effective date: 19880311